Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Washington (AP)

FDA panel backs Medtronic brain stimulator

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Federal health advisers say a brain stimulating device from Medtronic can be approved for epilepsy, provided the company conducts follow-up safety studies.

The Food and Drug Administration's panel of neurological experts voted 7-5 in favor of Medtronic's Deep Brain Stimulation implant, under certain conditions.

The experts said it should carry warning about depression and memory loss. They also said Medtronic should track patient safety for five years

The FDA is not required to follow the panel's advice, though it usually does.

Medtronic has asked the FDA to approve its implant for reducing seizures caused by epilepsy, a neurological disease.

The device is already approved for other movement disorders, including Parkinson's Disease.